Viking Therapeutics' highly anticipated readout of its oral anti-obesity pill showed a placebo-adjusted weight loss of 6.8% after four weeks, sticking the biotech near the front of ...

In the phase 3 Essence trial ... were reached given patients’ tendency to quit the GLP-1 medicine when taking it for weight loss. All told, Novo’s Essence readout vindicates the company ...

Doctors have blamed the Atkins diet for a worrying increase in the problem of constipation - a key factor in causing bowel cancer. Specialists claim that rising sales of laxatives and other ...

However, rapid weight loss results in a greater loss of muscle mass than losing weight slowly. With the widespread use of glucagon-like peptide 1 (GLP-1) receptor agonist drugs, which are very ...

Ferozan has 20 years of experience writing and editing in the health, wellness, and celebrity realm. We offer the most up-to-date information from top experts, new research, and health agencies, but ...

A box containing injectable vials of the weight-loss drug Wegovy in Brighton, Mich. on June 8, 2023. (CYDNI ELLEDGE) ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class ...

The MIND diet is not a mere weight-loss plan but an eating strategy aimed specifically at keeping your brain healthy. Here’s how to do it Most of us would do anything to avoid dementia.

Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds By Ernie Mundell HealthDay Reporter FRIDAY, Oct. 25, 2024 (HealthDay News) -- As the popularity of GLP-1 meds like Wegovy and ...

These kinds of changes need to be part of any weight-loss treatment, and kids taking a GLP-1 drug may need support from a variety of experts such as dietitians, social workers and food education ...

Boeing reported a massive third-quarter loss of more than $6 billion, as the airplane manufacturer was dragged down by a strike and billions in charges tied to its commercial aircraft and defense ...

The phase 1, open label clinical study is designed to enroll up to 10 participants and is being conducted in Johannesburg, Pretoria, and Bloemfontein, South Africa. This is the first cellular ...